WallStreetZenWallStreetZen

NASDAQ: ADVM
Adverum Biotechnologies Inc Stock Ownership - Who owns Adverum Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adverum Biotechnologies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laurent FischerCEO PRESIDENT AND DIRECTOR2025-05-159,126$2.00
$18.25kSell
Setareh SeyedkazemiCHIEF DEVELOPMENT OFFICER2025-05-15924$2.00
$1.85kSell
Peter SoparkarCHIEF OPERATING OFFICER2025-05-152,960$2.00
$5.92kSell
Braden Michael Leonard10% Owner2025-04-2350,000$2.98
$148.95kBuy
Braden Michael Leonard10% Owner2025-04-22300,000$3.00
$900.00kBuy
Braden Michael Leonard10% Owner2025-04-0215,209$4.04
$61.41kBuy
Braden Michael Leonard10% Owner2025-03-3119,566$4.38
$85.66kBuy
Braden Michael Leonard10% Owner2025-03-2716,593$5.19
$86.08kBuy
Braden Michael Leonard10% Owner2025-03-2716,593$5.19
$86.08kBuy
Braden Michael Leonard10% Owner2025-03-2716,593$5.19
$86.08kBuy

1 of 2

ADVM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADVM insiders and whales buy or sell their stock.

ADVM Shareholders

What type of owners hold Adverum Biotechnologies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard39.54%8,729,613$37.45MInsider
Versant Ventures IV LLC31.72%7,003,892$30.05MInsider
Bml Capital Management LLC13.85%3,057,526$13.12MInstitution
Zygtech LLC11.04%2,438,176$10.46MInsider
Venrock Associates VI LP10.71%2,365,471$10.15MInsider
Venrock Healthcare Capital Partners II LP10.71%2,365,471$10.15MInsider
James E. Flynn9.95%2,197,679$9.43MInsider
Frazier Life Sciences Management LP9.41%2,077,431$8.91MInstitution
Regeneron Pharmaceuticals Inc8.19%1,809,098$7.76MInsider
Tcg Crossover Management LLC7.56%1,668,174$7.16MInstitution

1 of 3

ADVM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADVM24.19%75.81%Net Buying
ATRA14.03%85.97%Net Buying
ANEB40.89%59.11%Net Buying
RPTX53.93%46.07%Net Selling
ZNTL62.31%37.69%Net Buying
View Top Biotech Stocks

Adverum Biotechnologies Stock Ownership FAQ

Who owns Adverum Biotechnologies?

Adverum Biotechnologies (NASDAQ: ADVM) is owned by 46.78% institutional shareholders, 146.57% Adverum Biotechnologies insiders, and 0.00% retail investors. Braden Michael Leonard is the largest individual Adverum Biotechnologies shareholder, owning 8.73M shares representing 39.54% of the company. Braden Michael Leonard's Adverum Biotechnologies shares are currently valued at $37.28M.

If you're new to stock investing, here's how to buy Adverum Biotechnologies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.